ISO 14971 Risk Management Consulting

ISO 14971 is an internationally recognized standard for managing risks associated with medical devices throughout their lifecycle. It provides a structured approach covering risk analysis, risk evaluation, risk control, benefit–risk assessment, and ongoing monitoring. The process applies to medical devices, IVDs, and software-based medical devices such as SaMD.

ISO 14971 helps manufacturers systematically identify hazards, evaluate associated risks, implement appropriate controls, and monitor residual risks. A documented risk-management process also supports regulatory compliance and product safety. Risk management can be integrated with quality systems, design controls, clinical or performance evaluation, and post-market surveillance activities.

An ISO 14971 risk-management process generally includes risk-management planning, hazard identification, risk analysis, risk evaluation, implementation of risk controls, evaluation of residual risk, benefit–risk assessment, and production and post-production monitoring. These activities should be documented and maintained throughout the medical device lifecycle.

A risk management file is the documented collection of records demonstrating that risk-management activities have been performed and maintained for a medical device. It can include hazard identification, probability and severity assessments, risk-control measures, residual-risk evaluations, benefit–risk assessments, and traceability to design, usability, and post-market information.

Risk management can be integrated into the Quality Management System established under ISO 13485. Risk considerations can influence design controls, documentation, production processes, and post-market activities. Integrating these processes helps maintain traceability between identified risks, implemented controls, design activities, and ongoing monitoring throughout the device lifecycle.

Risk analysis may use structured techniques appropriate to the device and its hazards. The provided service scope identifies methods and tools such as Failure Mode and Effects Analysis (FMEA/FMECA), Fault Tree Analysis, and Hazardous/Hazardous Event analysis. These methods can support systematic identification and evaluation of potential failure modes and hazards.

Risk control involves implementing measures to reduce identified risks to acceptable levels. After controls are applied, the remaining risk is evaluated as residual risk. Manufacturers must assess whether residual risks are acceptable and, where appropriate, perform a benefit–risk assessment. These evaluations should be documented within the risk-management process.

Post-market information can provide real-world evidence about device safety and performance. Manufacturers can integrate vigilance reports, PMS activities, PMCF or PMPF information, complaint data, and trend analysis into ongoing risk management. New information may require risk files to be reviewed and updated when previously identified risks or new hazards change.

ISO 14971:2019 migration support involves assessing existing risk-management processes and documentation against the requirements and expectations associated with the newer edition. Activities can include gap analysis, identifying deficiencies in methodology or evidence, updating procedures and templates, and developing remediation plans for existing risk-management documentation.

Yes. Risk management is relevant to software-based medical devices, including SaMD and AI-enabled devices. The risk process needs to consider hazards and risks associated with the device’s software functionality and intended use, while maintaining appropriate documentation and lifecycle monitoring. Risk management can also be connected with cybersecurity, usability, design, and post-market activities.